The largest database of trusted experimental protocols

Ly6g 1a8 pe cy7

Manufactured by BD

The Ly6G 1A8-PE Cy7 is a fluorescent-labeled antibody used in flow cytometry applications. It targets the Ly6G antigen, which is expressed on the surface of neutrophils. The antibody is conjugated with the PE-Cy7 fluorophore, allowing for the detection and analysis of Ly6G-positive cells.

Automatically generated - may contain errors

2 protocols using ly6g 1a8 pe cy7

1

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were washed with PBS and blocked with PBS plus 5% FBS, 2.5% mouse serum and 0.5% anti Fcγ III/II (anti-CD16/32) for 15min. Cells were washed with PBS and incubated with viability dye (1:500, eBioscience) and antibodies (1:200) for 15 min. Cells were washed with PBS and analyzed by LSR II (BD Biosciences). Flow cytometric data were further analyzed with FlowJo software (TreeStar).
For intracellular staining, cells were incubated with Brefeldin A (1:1000, eBioscience) in RPMI media plus 10% FBS in 37 C for 4–5h. Then cells were washed, blocked and stained according to the Intracellular Staining protocol (eBioscience). Cells were washed with PBS and analyzed by BD LSR II.
Antibodies used in this paper include Ly6C-APC Cy7, Ly6C-APC, F4/80-PE, F4/80-e450, Ly6G 1A8-PE Cy7, Ly6G 1A8-FITC (BD), CD45.2-APC, CD45.2-AF700, CD45.1-PE, CD45.1-AF700, CD3-e450, NK1.1-AF780, CD11b-PerCP Cy5.5 (BD), CD206-PE, Arginase1-PE (R & D), Anti-mouse Relm-α antibody (PeproTech). Antibodies were from eBioscience unless stated otherwise.
+ Open protocol
+ Expand
2

Antibody Panel for Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were obtained from eBioscience: CD11b (M1/70)-APC-eFluor 780, CD11c (N418)-PerCP-Cyanine5.5, CD45.1 (A20)-FITC and PE, CD45R/B220 (RA3-6B2)-PE, and Ki-67 (SolA15)-PE-Cyanine7. The following antibodies were obtained from Invitrogen: CD45 (30-F11)-eFluor 450 and GM-CSF (MP1-22E9)-FITC. The following antibodies were obtained from BD Pharmingen: Ly6G (1A8)-PE-Cy7. The following antibodies were obtained from BioLegend: CD4 (RM4-5)-APC. For in vivo GM-CSF blocking experiments, 500 μg of anti–mouse GM-CSF (MP1-22E9) or rat IgG2a isotype control (2A3) (BioXCell) was administered via i.p. injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!